By Dr Ann McCormack

Journal articles

Raverot G; Burman P; McCormack A; Heaney A; Petersenn S; Popovic V; Trouillas J; Dekkers OM, 2018, 'European society of endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas', European Journal of Endocrinology, 178, pp. G1 - G24, http://dx.doi.org/10.1530/EJE-17-0796

Sheriff N; McCormack AI, 2017, 'How useful is urinary-free cortisol in the clinic?', Biomarkers in Medicine, 11, pp. 1009 - 1016, http://dx.doi.org/10.2217/bmm-2016-0311

McCormack AI; Burt MG, 2017, 'Optimising pituitary surgery outcomes in Australia: how much does size matter?', Internal Medicine Journal, 47, pp. 1225 - 1227, http://dx.doi.org/10.1111/imj.13610

De Sousa SMC; McCormack AI; McGrath S; Torpy DJ, 2017, 'Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease', Clinical Endocrinology, 87, pp. 515 - 522, http://dx.doi.org/10.1111/cen.13401

Casanueva FF; Barkan AL; Buchfelder M; Klibanski A; Laws ER; Loeffler JS; Melmed S; Mortini P; Wass J; Giustina A; Lomba AA; Abucham J; Alvarez-Escola C; Barkan AL; Beckers A; Ben-Shlomo A; Bernabeu I; Bidlingmaier M; Biermasz N; Biller B; Boguszewski CL; Bolanowski M; Bollerslev J; Bonert V; Bronstein M; Bruno OD; Carmichael JD; Caron P; Chanson P; Casanueva FF; Clayton RN; Colao A; Cordido F; De Marinis L; Fahlbusch R; Fleseriu M; Formenti AM; Freda PU; Fukuoka H; Ghigo E; Greenman Y; Grineva E; Grossman A; Gurnell M; Heaney A; Hoffman AR; Ilovayskaya I; Johannsson G; Kadioglu P; Karavitaki N; Katznelson L; Kelestimur F; Kelly DF; Ho K; Krsek M; Lacroix A; Laws ER; StevenLoeffler J; Losa M; Jørgensen JO; Luger A; Mallea-Gil S; Mamelak A; Mazziotti G; McCormack A; Mercado M; Neggers S; Ning G; Oyesiku NM; Popovic V; Petakov M; Petersenn S; Pfeifer M; Pico A; Domingo MP; Raverot G; Reincke M; Gadelha MR; Salvatori R; Samson SL; Shimatsu A; Shimon I; Stewart P; Strasburger C; Swearingen B; Trainer P; Tritos NA; Tsagarakis S; van der Lely AJ; Vilar L; Villar-Taibo R; Zatelli MC, 2017, 'Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement', Pituitary, 20, pp. 489 - 498, http://dx.doi.org/10.1007/s11102-017-0838-2

McCormack A; Dekkers OM; Petersenn S; Popovic V; Trouillas J; Raverot G; Burman P, 2017, 'Use of temozolomide in a large cohort of patients with aggressive pituitary tumours and pituitary carcinomas: Results from a European Society of Endocrinology (ESE) survey', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.49.oc12.2

De Sousa SMC; McCabe MJ; Wu K; Roscioli T; Gayevskiy V; Brook K; Rawlings L; Scott HS; Thompson TJ; Earls P; Gill AJ; Cowley MJ; Dinger ME; McCormack AI, 2017, 'Germline variants in familial pituitary tumour syndrome genes are common in young patients and families with additional endocrine tumours', European Journal of Endocrinology, 176, pp. 635 - 644, http://dx.doi.org/10.1530/EJE-16-0944

McCormack A, 2017, 'The role of genetic testing in pituitary tumours - who to test?', CLINICAL ENDOCRINOLOGY, 86, pp. 31 - 31, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000393453600087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

De Sousa SMC; Maiti K; Smith R; McCormack AI, 2016, 'Corticotrophin-releasing hormone (CRH) expression in the dermoid component of ovarian teratomas', Journal of the European Academy of Dermatology and Venereology, 30, pp. 867 - 869, http://dx.doi.org/10.1111/jdv.13035

Trainer P; Newell-Price J; Ayuk J; Aylwin S; Rees A; Drake W; Chanson P; Brue T; Webb S; Fajardo C; Aller J; McCormack A; Torpy D; Atley L; Tachas G, 2015, 'Antisense oligomer therapy directed at the GH receptor is associated with reduction in circulating GHBP levels', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.38.p308

Trainer P; Newell-Price J; Ayuk J; Aylwin S; Rees A; Drake W; Chanson P; Brue T; Webb S; Fajardo C; Aller J; McCormack A; Torpy D; Tachas G; Atley L; Bidlingmaier M, 2015, 'A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly.', Endocrine Abstracts, http://dx.doi.org/10.1530/endoabs.37.gp.19.10

De Sousa SMC; Earls P; McCormack AI, 2015, 'Pituitary hyperplasia: case series and literature review of an under-recognised and heterogeneous condition.', Endocrinol Diabetes Metab Case Rep, 2015, pp. 150017, http://dx.doi.org/10.1530/EDM-15-0017

Trainer PJ; Newell-Price J; Ayuk J; Aylwin S; Drake WM; Rees A; Chanson P; Brue T; Webb SM; Fajardo C; Aller J; McCormack A; Torpy DJ; Tachas G; Atley LM; Bidlingmaier M, 2014, 'OR7-8: A phase II randomised, open-label, parallelgroup study of the safety, tolerability, pharmacokinetics and efficacy of two subcutaneous dosing regimens of ATL1103 in adult patients with acromegaly', Growth Hormone & IGF Research, 24, pp. S21 - S21, http://dx.doi.org/10.1016/s1096-6374(14)50054-8

Naziat A; Karavitaki N; Thakker R; Ansorge O; Sadler G; Gleeson F; Cranston T; McCormack A; Grossman AB; Shine B, 2013, 'Confusing genes: A patient with MEN2A and Cushing's disease', Clinical Endocrinology, 78, pp. 966 - 968, http://dx.doi.org/10.1111/cen.12072

McCormack A; Kaplan W; Gill AJ; Little N; Cook R; Robinson B; Clifton-Bligh R, 2013, 'MGMT expression and pituitary tumours: Relationship to tumour biology', Pituitary, 16, pp. 208 - 219, http://dx.doi.org/10.1007/s11102-012-0406-8

Shein TT; Costin ML; McCormack A; Parker A; Earls P, 2013, 'Atypical pituitary adenomas – investigation and validation of the 2004 who criteria', Pathology, 45, pp. S83 - S84, http://dx.doi.org/10.1097/01.pat.0000426942.30252.de

Rostomyan L; Daly A; Lila A; Lecoq A-L; Nachev E; Moraitis A; Naves L; Kranenburg D; Holdaway I; Filipponi S; Sievers C; Sahnoun-Fathallah M; Ojaniemi M; Sorkina E; Tichomirowa M; Ilovaiskaya I; Zacharin M; Bertherat J; Malchiodi E; Salvatori R; Barbosa SL-S; Maiter D; Mccormack A; Von Werder K; Rozhinskaya L; Dal J; Nazzari E; Auriemma R; Metzger D; Jorgensen JO; Dreval A; Ebeling T; Ferone D; Stalla G; Beck-Peccoz P; Aaltonen L; Colao A; Pronin V; Barlier A; Brue T; Rohmer V; Mukhopadhyay S; Borson-Chazot F; Neggers S; Jaffrain-Rea ML; Stratakis C; Chanson P; Zacharieva S; Petrossians P; Shah N; Beckers A, 2013, 'Le Gigantisme : les résultats d’une étude clinique et génétique internationale', Annales d'Endocrinologie, 74, pp. 260 - 261, http://dx.doi.org/10.1016/j.ando.2013.07.083

Greenfield JR; Mccormack AI, 2012, 'Medication to prevent breast cancer too much to swallow?', Medical Journal of Australia, 196, pp. 314, http://dx.doi.org/10.5694/mja12.10056

McCormack A, 2012, 'Temozolomide in the treatment of aggressive pituitary tumours - an overview of existing knowledge and future perspectives', European Endocrinology, 8, pp. 116 - 121, http://dx.doi.org/10.17925/ee.2012.08.02.116

McCormack A, 2012, 'Temozolomide in the treatment of aggressive pituitary tumours - An overview of existing knowledge and future perspectives', European Neurological Review, 7, pp. 228 - 233, http://dx.doi.org/10.17925/enr.2012.07.04.228

McCormack A, 2012, 'Tmozolomide in the treatment of aggressive pituitary tumors - An overview of existing knowledge and future perspectives', US Endocrinology, 8, pp. 112 - 117, http://dx.doi.org/10.17925/use.2012.08.02.112

Mccromack A; Wass J; Grossman AB, 2011, 'Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status', European Journal of Clinical Investigation, 41, pp. 1133 - 1148

Thompson J; Collett L; Langbart M; Purcell NJ; Boyd SJ; Yuminaga Y; Mccromack A, 2011, 'Using the ISBAR handover tool in junior medical officer handover: a study in a Australian tertiary hospital', Postgraduate Medical Journal, 87, pp. 340 - 344, http://dx.doi.org/10.1136/pgmj.2010.105569

Losa M; Mazza E; Terreni MR; McCormack A; Gill AJ; Motta M; Cangi MG; Talarico A; Mortini P; Reni M, 2010, 'Salvage therapy with temozolomide in patients with aggressive or metastatic pituitary adenomas: Experience in six cases', European Journal of Endocrinology, 163, pp. 843 - 851, http://dx.doi.org/10.1530/EJE-10-0629

McCormack A, 2010, 'Adult pituitary disease', Australian Doctor, pp. 23 - 30

Glasziou P; Alexander J; Beller E; Clarke P; Chalmers J; MacMahon S; Cooper M; Ferrannini E; Grobbee D; Hamet P; Harrap S; Heller S; Lisheng L; Mancia G; Marre M; Mogensen C; Neal B; Yu Pan C; Patel A; Poulter N; Rodgers A; William B; Woodward M; Collins R; Holman R; Sleight P; Adams M; Branley M; Fulcher G; Jenkins B; Louis D; Lou W; Lowe H; McCormack A; Mitchell P; Ong S; Pollock C; Watson J; Wong T; Allen S; Bompoint S; Carreras A; Chen T; Flynn S; Gibbo S; Han D; Hough S; Jayne K; Joshi R; Kengne AP; Linn J; Monaghan H; Ng R; Perkovic V; Regaglia J; Schmidt M; Xin D; Yufang B; Holloway T; Gray B; Milne A; Adderkin A; Guertin MR; de Guise D; Liyuan M; Reid J; Subramaniam R; Wen W; Williamson K, 2007, 'Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial', Health and Quality of Life Outcomes, 5, pp. 21, http://dx.doi.org/10.1186/1477-7525-5-21

McCormack AI; Learoyd DL, 2006, 'A guide to thyroid dysfunction', Medicine Today, 7, pp. 28 - 35

Byrne MF; Chong HI; O'Donovan D; Sheehan KM; Leader MB; Kay E; McCormack A; Broe P; Murray FE, 2003, 'Idiopathic cholangiopathy in a biliary cast syndrome necessitating liver transplantation following head trauma', EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 15, pp. 415 - 417, http://dx.doi.org/10.1097/00042737-200304000-00013

Rutkowski A; Dubinsky I, 1999, 'Ovarian hyperstimulation syndrome: Imperatives for the emergency physician', Journal of Emergency Medicine, 17, pp. 669 - 672, http://dx.doi.org/10.1016/S0736-4679(99)00062-1

Back to profile page